Horse Profile

Screener/Chateau Eze (GB)

Chateau Eze (GB)

3yo Filly · Bay · GB

Career Overview

Chateau Eze (GB) is a 3yo bay filly, trained by Mark Walker and owned by Fairway Thoroughbreds. He is by Frankel (GB), out of Antibes (AUS), by Lonhro, bred by Fairway Thoroughbreds Pty Ltd. From 3 career starts, he is yet to win, at a 0.0% strike rate. He has earned £7.4k in prize money. He holds an official rating of 70.

AI summary — career highlights, form & what to expect

Chateau Eze (GB)(GB)

Frankel (GB) — Antibes (AUS) (Lonhro)

Form
640
Active

Age

3

Sex

Filly

Colour

Bay

OR

70

TF

—

Runs

3

Wins

0

Places

0

BreederFairway Thoroughbreds Pty Ltd
Prize Money£7.4k

Performance Metrics

Win Rate

0.0%

Place Rate

0.0%

Total Runs

3

Best OR

70

Career Earnings

£7.4k

Ratings & Form History

Official Rating · Speed Figure · Finishing Position

18 Oct 2507 Feb 2621 Feb 2665687175
  • Finish Pos.
  • Off. Rating
  • Speed Fig.

Earnings Per Race

£7.4k total
07 Feb 2621 Feb 26£0£1.5k£3k£4.5k£6k

Pedigree

Breeder

Fairway Thoroughbreds Pty Ltd

Racing TypeFlat
ColourBay
StatusActive

Performance Analysis

Going Preference

Good3
0W 0P 0%

Seasonal Form

Feb2
0W 0P 0%
Oct1
0W 0P 0%

Headgear Impact

With3
0W 0P 0%

Draw Performance

Low (1-3)1
0W 0P · Avg 4.0
High (7+)2
0W 0P · Avg 8.5

Jockey Record

Course Form

Beaten Distances

Avg Win Margin

—

Avg Beaten

0.8L

Closest Loss

0.3L

Rating Trends (RPR · TS · OR)

07 Feb 2621 Feb 26020406080
  • RPR
  • TS
  • OR

Market Trend (Starting Price)

18 Oct 2507 Feb 2621 Feb 26015304560
  • SP (dec)
  • BSP

Race History

Race History

DatePosTrackRaceDistGoingJockeySPORSpeed
21 Feb 20266Caulfield (AUS)Sportsbet Angus Armanasco Stakes (Fillies) (Turf)7ffGoodJordan Childs8/170—
07 Feb 20264Caulfield (AUS)Evergreen Turf Peter Le Grand Stakes (Fillies) (Turf)5.5ffGoodJordan Childs30/170—
18 Oct 202511Caulfield (AUS)Schweppes Thousand Guineas (3yo Fillies) (Turf)8ffGoodDaniel Stackhouse17/1——

Discussion

0 comments

You must be logged in to leave a comment.

No comments yet

Be the first to share your thoughts